Examples of using Adrs in English and their translations into Danish
{-}
-
Medicine
-
Official
-
Colloquial
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
The ADRs that appeared to be dose-related included weight increased,
of 0,005% the frequency of these ADRs can be classified as very rare.
The following are all ADRs that were reported in INVEGA-treated subjects in clinical trials.
Rare and very rare ADRs cannot be detected based on the number of patients included in the DUET trials.
Chinese and Russian ADRs.
The ADRs reported in the two studies are summarised
ADRs only reported during the Post Marketing period are also included in the table below at a frequency category of“ unknown”.
In the congenital heart disease study no medically important differences were observed in ADRs by body system or when evaluated in subgroups of children by clinical category.
This table excludes those ADRs specifically associated with the formulation
The frequencies of ADRs reported with MabThera alone
Summary of ADRs occurring in patients with RA receiving tocilizumab as monotherapy
ADRs of all severity grades
You may cancel your ADR online as long as there are multiple ADRs on your account.
Re-treatment The percentage of patients reporting ADRs upon re-treatment with further courses of MabThera was similar to the percentage of patients reporting ADRs upon initial exposure any grade
Some of the ADRs are reactions commonly seen with the combination agent(e. g. peripheral sensory neuropathy with docetaxel
the CHMP considered that the proposed extensive use of footnotes has little value for the prescriber and ADRs have been moved to the frequency category representing the highest frequency see attached SPC and PIL.
Table 4 lists ADRs associated with the use of Xeloda monotherapy based on a pooled analysis of safety data from three major studies including over 1900 patients studies M66001,
ADRs reported in abatacept-treated patients which did not occur with an excess incidence(i. e. the difference was not>
the data processing network through the availability of new functionalities Manage all pharmacovigilance information(ADRs, PSURs) in a timely manner Strengthen the conduct of pharmacovigilance for centrally authorised medicinal products through a more in-depth
the national authority to make practical arrangements with national ADRs to ensure smooth cooperation